APO-Adefovir (adefovir) Drug / Medicine Information

jhon yudha

Contains the active ingredient adefovir (as adefovir dipivoxil)

Consumer Medicine Information

What is in this leaflet

Read this leaflet carefully before taking your medicine.

This leaflet answers some common questions about adefovir. It does not contain all the available information. It does not
take the place of talking to your doctor or pharmacist.

The information in this leaflet was last updated on the date listed on the last page. More recent information on this medicine
may be available.

Ask your doctor or pharmacist:

if there is anything you do not understand in this leaflet,

if you are worried about taking your medicine, or

to obtain the most up-to-date information.

You can also download the most up to date leaflet from www.apotex.com.au.

All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the benefits they
expect it will have for you.

Pharmaceutical companies

Read More

Opioids continue to be the leading cause of overdose deaths in Australia. What else can we do?

jhon yudha

In 2018, more than 2,000 people died from drug overdoses in Australia — about five each day.

That’s according to the Penington Institute’s annual overdose report, released today.

The largest number of overdose deaths (more than 1,000) involved opioids (for example, heroin, morphine, oxycodone, fentanyl), followed by benzodiazepines (for example, Valium).

Opioid-related deaths in Australia have been on an upward trend in recent years, having doubled since 2006. This means we’re now not far off numbers recorded in the late 1990s, when opioid-related deaths were highest. There’s more we could be doing to curb this problem.

What kind of opioids are causing harm?

Unlike North America, where illicitly manufactured fentanyl has been involved in many opioid deaths, most opioid deaths in Australia involve pharmaceutical opioids.

That said, heroin deaths have increased over the past five years.

Among all opioid deaths, just over half of people overdosing have a history of

Read More

Depression in British adults may have doubled during coronavirus pandemic

jhon yudha

Some 19.2% of British adults likely had some form of depression in June, up from 9.7% before the pandemic, said the UK’s Office for National Statistics (ONS) in a report. Conversely, 3.5% of adults experienced an improvement in their symptoms of depression.

“Adults who were young, female, unable to afford an unexpected expense or disabled were the most likely to experience some form of depression during the pandemic,” said Tim Vizard, principal research officer at the ONS.

A large majority (84.9%) of adults experiencing some form of depression said they had been feeling stressed and anxious, and 42.2% said their relationships were being affected. In comparison, 20.7% of adults with no sign of depression said Covid-19 was impacting their relationships.

The results are based on a nationally representative survey of adults in Britain, the Opinions and Lifestyle Survey, which asks a series of questions in order to produce a score

Read More

Entecavir APO (entecavir) Drug / Medicine Information

jhon yudha

Contains the active ingredient entecavir (as monohydrate)

Consumer Medicine Information

What is in this leaflet

Read this leaflet carefully before taking your medicine.

This leaflet answers some common questions about entecavir. It does not contain all
the available information. It does not take the place of talking to your doctor or
pharmacist.

The information in this leaflet was last updated on the date listed on the last page.
More recent information on this medicine may be available.

Ask your doctor:

if there is anything you do not understand in this leaflet,

if you are worried about taking your medicine, or

to obtain the most up-to-date information.

You can also download the most up to date leaflet from www.apotex.com.au.

All medicines have risks and benefits. Your doctor has weighed the risks of you using
this medicine against the benefits they expect it will have for you.

Pharmaceutical companies cannot give you

Read More

Lamivudine + Zidovudine Alphapharm (lamivudine and zidovudine) Drug / Medicine Information

jhon yudha

lamivudine and zidovudine

CONSUMER MEDICINE INFORMATION

What is in this leaflet

Please read this leaflet carefully before you start LAMIVUDINE 150mg + ZIDOVUDINE
300mg Alphapharm. This leaflet answers some common questions about LAMIVUDINE 150mg
+ ZIDOVUDINE 300mg Alphapharm.

It does not contain all the available information. It does not take the place of talking
to your doctor or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking
LAMIVUDINE 150mg + ZIDOVUDINE 300mg Alphapharm against the benefits they expect it
will have on you.

If you have any concerns about taking this medicine, talk to your doctor or pharmacist.

Keep this leaflet with your medicine.

You may need to read it again.

What LAMIVUDINE 150mg + ZIDOVUDINE 300mg Alphapharm is used for

LAMIVUDINE 150mg + ZIDOVUDINE 300mg Alphapharm contains lamivudine and zidovudine
which belongs to a group of medicines called antiretrovirals.

Please note that

Read More

APO-Fluconazole (fluconazole) Drug / Medicine Information

jhon yudha

Contains the active ingredient fluconazole

Consumer Medicine Information

What is in this leaflet

Read this leaflet carefully before taking your medicine.

This leaflet answers some common questions about fluconazole. It does not contain all the available information. It does not
take the place of talking to your doctor or pharmacist.

The information in this leaflet was last updated on the date listed on the last page. More recent information on your medicine
may be available.

Ask your doctor or pharmacist:

if there is anything you do not understand in this leaflet,

if you are worried about taking your medicine, or

to obtain the most up-to-date information.

You can also download the most up to date leaflet from www.apotex.com.au.

All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the benefits they
expect it will have for you.

Pharmaceutical companies cannot give you

Read More

APO-Duloxetine (duloxetine) Drug / Medicine Information

jhon yudha

Contains the active ingredient duloxetine (as duloxetine hydrochloride)

Consumer Medicine Information

What is in this leaflet

This leaflet answers some common questions about this medicine. It does not contain
all the available information. It does not take the place of talking to your doctor
or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking
this medicine against the benefits they expect it will have for you.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Keep this leaflet with the medicine.

You may need to read it again.

What this medicine is used for

Duloxetine is used to treat:

major depressive disorder (MDD)

generalised anxiety disorder (GAD) – excessive worry

Duloxetine belongs to a group of medicines called serotonin and noradrenaline reuptake
inhibitors (SNRIs). SNRIs are believed to work by their action on serotonin and noradrenaline
in the

Read More

Bi Eligard cp (bicalutamide & leuprorelin acetate) Drug / Medicine Information

jhon yudha

bicalutamide & leuprorelin acetate

Consumer Medicine Information

What is in this leaflet

This leaflet answers some common questions about Bi ELIGARD cp. It does not contain
all the available information. It does not take the place of talking to your doctor
or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking
Bi ELIGARD cp against the benefits they expect it will have for you.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Keep this leaflet with the medicine.

You may need to read it again.

What Bi ELIGARD cp is used for

Bi ELIGARD cp combination therapy is the brand name for packs containing ELIGARD (leuprorelin
acetate) 7.5 mg or 22.5 mg subcutaneous injection plus MPL-BICALUTAMIDE 50 mg tablets.

Bi ELIGARD cp is used to reduce the symptoms of advanced cancer of the prostate gland.

Bicalutamide tablets

Read More

APO-Naltrexone (Naltrexone) Drug / Medicine Information

jhon yudha

Contains the active ingredient Naltrexone (as Naltrexone Hydrochloride)

Consumer Medicine Information

What is in this leaflet

Read this leaflet carefully before taking your medicine.

This leaflet answers some common questions about naltrexone. It does not contain all the available information. It does not
take the place of talking to your doctor or pharmacist. Your doctor has been provided with full information and can answer
any questions you may have. Follow your doctor’s advice even if it is different from what is in this leaflet.

The information in this leaflet was last updated on the date listed on the last page. More recent information on this medicine
may be available.

Ask your doctor or pharmacist:

if there is anything you do not understand in this leaflet,

if you are worried about taking your medicine, or

to obtain the most up-to-date information.

You can also download the most up to date leaflet

Read More

APO-Exemestane (exemestane) Drug / Medicine Information

jhon yudha

Contains the active ingredient exemestane

Consumer Medicine Information

What is in this leaflet

Read this leaflet carefully before taking your medicine.

This leaflet answers some common questions about exemestane. It does not contain all the available information. It does not
take the place of talking to your doctor or pharmacist.

The information in this leaflet was last updated on the date listed on the last page. More recent information on this medicine
may be available.

Ask your doctor or pharmacist:

if there is anything you do not understand in this leaflet,

if you are worried about taking your medicine, or

to obtain the most up-to-date information.

You can also download the most up to date leaflet from www.apotex.com.au.

All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the benefits they
expect it will have for you.

Pharmaceutical companies cannot give you

Read More